Change in bowel habits during menstruation: are IBD patients different?
article
OA: gold
CC0
⤵ 1 in-corpus citation
Abstract
BACKGROUND AND AIM: Many female inflammatory bowel disease (IBD) patients report symptoms exacerbation before and during menses. Our aim was to characterize their symptoms and specific risk factors in comparison with healthy controls. METHODS: Female IBD patients aged 18-50 years were asked to fill out a questionnaire recording their demographic and disease characteristics, menstruation history and symptoms. Disease activity was defined by Harvey-Bradshaw index (HBI) for Crohn's disease (CD) patients and modified mayo score for ulcerative colitis (UC) patients. Healthcare providers answering an internet survey assessing bowel symptoms during menstruation served as healthy controls. RESULTS: < 0.01 for most parameters). Smoking status, biologic treatment, and previous abdominal operation were found to significantly aggravate symptoms during menses in IBD patients. CONCLUSION: IBD patients experience various symptoms during menses significantly more commonly than healthy women. Smoking, biologic treatment, and previous abdominal operations are risk factors for higher symptomatic burden. Following future validation and research, these results can help in patients' risk stratification and possibly in risk reduction.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (2)
- The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study 1998
- Pattern of gastrointestinal and psychosomatic symptoms across the menstrual cycle in women with inflammatory bowel disease. 2003
Cited by (1)
References (29)
- Pattern of gastrointestinal and psychosomatic symptoms across the menstrual cycle in women with inflammatory bowel disease. via openalex
- The menstrual cycle and its effect on inflammatory bowel disease and irritable bowel syndrome: a prevalence study via openalex
- doi:10.1111/j.1572-0241.1998.540_i.x via openalex
- doi:10.1097/mib.0000000000000134 via openalex
- doi:10.3748/wjg.v20.i33.11496 via openalex
- doi:10.5009/gnl.2013.7.1.51 via openalex
- doi:10.18632/oncotarget.6217 via openalex
- doi:10.1111/nmo.13025 via openalex
- doi:10.1016/j.mce.2017.07.036 via openalex
- doi:10.1080/07399338809515818 via openalex
- W89284354 via openalex
- doi:10.1158/1078-0432.ccr-13-0325 via openalex
- W1416438915 via openalex
- doi:10.1016/0016-5085(81)90263-8 via openalex
- doi:10.1002/ibd.20873 via openalex
- doi:10.1002/(sici)1098-240x(199602)19:1<45::aid-nur5>3.0.co;2-l via openalex
- doi:10.1111/j.1572-0241.2008.01980.x via openalex
- doi:10.1093/ibd/izx004 via openalex
- doi:10.1016/j.jpain.2012.11.008 via openalex
- doi:10.1186/1472-6874-14-14 via openalex
- doi:10.1038/clpt.2010.226 via openalex
- W2976320863 via openalex
- W2991820278 via openalex
- doi:10.3892/ol.2019.10983 via openalex
- doi:10.1016/j.jpain.2012.04.010 via openalex
- doi:10.1111/apt.14832 via openalex
- doi:10.1111/j.1365-2036.2012.05155.x via openalex
- doi:10.1016/s0065-3101(22)00693-4 via openalex
- doi:10.1016/0016-5085(92)90097-i via openalex
Cited by (1)
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-05-11T04:39:38.315201+00:00
License: CC0
· commercial use OK